| Abstract: | The changes and complications in metabolic status and lipodystrophy stemming from HIV treatment are examined. Research results from international conferences are discussed; topics include mechanisms of action and outcomes of recent treatments for lipodystrophy. These therapies cite the benefits of diet and exercise and the use of liposuction. Also examined are studies that investigated the effects of switching HIV protease drugs. Concluding comments address the possible connection between heart disease and lipodystrophy. |
